Search research articles
Contact Us
Filters
Showing results (61-70 of 112) with videos related to
Page
of 12
Sort By:
The Journal of International Medical Research
|
December 11, 2020
Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review
Jinhua Yan, Zhongbo Chen, Yumei Liang, et al.
Annals of Hepatology
|
December 22, 2023
From NAFLD to MASLD: When metabolic comorbidity matters
Shan Hong, Lei Sun, Yiwei Hao, et al.
Zhonghua Yi Xue Za Zhi
|
April 16, 2002
[Transfer of cDNAs of platelet factor 4 and N-truncated peptide inhibits solid tumor growth in vivo]
Yanhan Li, Yongjun Liu, Yixin Jin, et al.
Frontiers in Pediatrics
|
June 29, 2026
Association between breastfeeding and lower risk of behavioral problems in children: a systematic review and meta-analysis
Xue Liu, Miao Liu, Hongli Chen, et al.
Pathology, Research and Practice
|
April 15, 2026
High-accuracy instance segmentation of cellular structures in head and neck squamous cell carcinoma histopathology using a cyto R-CNN deep learning framework
Rong Zeng, Yuling Zhou, Qinghui Wu, et al.
Medicine
|
July 14, 2015
Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population
Yvonne Lee Yin Leng, Yuling Zhou, Honghong Ke, et al.
Frontiers in Microbiology
|
March 29, 2021
High-Level Extracellular Expression of a New β-N-Acetylglucosaminidase in <i>Escherichia coli</i> for Producing GlcNAc
Congna Li, Shun Jiang, Chao Du, et al.
Scientific Reports
|
May 14, 2025
A TaqMan qPCR for precise detection and quantification of diarrheagenic Escherichia coli
Bingyu Xue, Huanrong Zhang, Xia Yan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 26, 2020
A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumab
Yuling Zhou, Wenjuan Jiang, Liang Zeng, et al.
Frontiers in Pharmacology
|
October 24, 2022
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Mengjiao Zhou, Danfeng Wang, Xiang Li, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 112) with videos related to
Sort By:
Page
of 12
The Journal of International Medical Research
|
December 11, 2020
Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review
Jinhua Yan, Zhongbo Chen, Yumei Liang, et al.
Annals of Hepatology
|
December 22, 2023
From NAFLD to MASLD: When metabolic comorbidity matters
Shan Hong, Lei Sun, Yiwei Hao, et al.
Zhonghua Yi Xue Za Zhi
|
April 16, 2002
[Transfer of cDNAs of platelet factor 4 and N-truncated peptide inhibits solid tumor growth in vivo]
Yanhan Li, Yongjun Liu, Yixin Jin, et al.
Frontiers in Pediatrics
|
June 29, 2026
Association between breastfeeding and lower risk of behavioral problems in children: a systematic review and meta-analysis
Xue Liu, Miao Liu, Hongli Chen, et al.
Pathology, Research and Practice
|
April 15, 2026
High-accuracy instance segmentation of cellular structures in head and neck squamous cell carcinoma histopathology using a cyto R-CNN deep learning framework
Rong Zeng, Yuling Zhou, Qinghui Wu, et al.
Medicine
|
July 14, 2015
Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population
Yvonne Lee Yin Leng, Yuling Zhou, Honghong Ke, et al.
Frontiers in Microbiology
|
March 29, 2021
High-Level Extracellular Expression of a New β-N-Acetylglucosaminidase in <i>Escherichia coli</i> for Producing GlcNAc
Congna Li, Shun Jiang, Chao Du, et al.
Scientific Reports
|
May 14, 2025
A TaqMan qPCR for precise detection and quantification of diarrheagenic Escherichia coli
Bingyu Xue, Huanrong Zhang, Xia Yan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 26, 2020
A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumab
Yuling Zhou, Wenjuan Jiang, Liang Zeng, et al.
Frontiers in Pharmacology
|
October 24, 2022
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Mengjiao Zhou, Danfeng Wang, Xiang Li, et al.
Page
of 12